Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT05592743
EAP: Expanded Access Use of Vorasidenib, for the treatment of IDH1 and IDH2 mutated Glioma
Status
Open
Conditions
Other
Phases
Pilot
Age Group
Adult
Main Investiagtor
Cavaliere, Robert
Practice
CNS
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05592743
Secondary Trial ID Number
VORA-EAP-01
Keywords
Treatment